Abstract:Background Previous research has found that multi-drug resistant (MDR) bacteria can be transmitted between ICU patients, and the infections caused by MDR bacteria may negatively affect the efficacy of current treatment. As the speed of diagnostic testing to identify MDR bacteria is relatively slow in clinical practice, the research regarding the prediction of MDR bacteria infections has developed. Objective To develop an evidence-based risk prediction model for MDR bacterial infections in ICU patients, and to verify it using the real-world clinical data collected retrospectively. Methods Potential risk factors for MDR bacterial infections in ICU patients were identified by a meta-analysis of studies regarding MDR bacterial infections in ICU patients included in databases of PubMed, EMBase, the Cochrane Library, CNKI, Wanfang, China Science and Technology Journal Database, Ace Base of CMA during January 2012 to June 2020 using Stata/SE 12.0 software, and were used to develop a risk prediction model by transforming effect size to the standardized regression (β) coefficient. Next the model was fully established and externally verified using the clinical data of adult ICU patients (n=3 908) recruited from Shanghai General Hospital from January 2018 to June 2021. ROC analysis was used to describe the predictive accuracy of the prediction model. Results Seventeen potential risk factors of MDR bacterial infections in ICU patients were identified through the meta-analysis of 31 included studies. The MDR bacterial infection risk prediction model incorporating these 17 factors with corresponding β value as coefficient (derived from converting the risk effect size of each factor) was developed: Logit (P) =-2.476 3 +0.086X1〔gender (male) 〕+0.191X2 (history of hospitalization) +0.392X3 (being transferred from another hospital) +1.723X4 (length of ICU stay) +0.315X5 (other infections) +0.385X6 (chronic obstructive pulmonary disease) +0.131X7 (diabetes) +0.536X8 (renal disease) +0.285X9 (renal failure) +0.565X10 (dialysis) +0.148X11 (mechanical ventilation) +0.742X12 (central venous catheter) +0.336X13 (urinary catheter) +3.483X14 (types of used antimicrobial drugs) +0.174X15 (history of antimicrobial use) +0.975X16 (history of carbapenems use) +1.151X17 (history of aminoglycosides use) . External verification of the model revealed that the model had 64.36% sensitivity, 80.39% specificity, and 0.447 4 Youden index, and an AUC of 0.724. Conclusion Our model has been proved to have good performance in predicting the MDR bacterial infection risk in ICU patients, as well as relatively good applicability, scientificity, and practicability. The development regimen may be used as a reference for developing a risk prediction model for other diseases.

Development and validation of a novel prediction model for Carbapenem-resistant organism infection in a large-scale hospitalized patients

A Nomogram With Six Variables Is Useful to Predict the Risk of Acquiring Carbapenem-Resistant Microorganism Infection in ICU Patients

Development and validation of a nomogram-based risk prediction model for carbapenem-resistant Klebsiella pneumoniae in hospitalized patients

Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate

Development and application of a risk nomogram for the prediction of risk of carbapenem-resistant Acinetobacter baumannii infections in neuro-intensive care unit: a mixed method study

Nomogram Based on Clinical Characteristics to Predict 28-Day Mortality Among Patients with CRAB-BSI

Development and validation of a prediction model for in-hospital mortality in patients with sepsis

Nomogram for predicting the risk of nosocomial infections among obstetric inpatients: a large-scale retrospective study in China

Development and validation of a predictive model for 30-day mortality in patients with severe community-acquired pneumonia in intensive care units

Nomogram for Predicting 90-Day Mortality in Patients with Acinetobacter Baumannii-Caused Hospital-Acquired and Ventilator-Associated Pneumonia in the Respiratory Intensive Care Unit.

Development and Validation of Nomogram for Hospital Mortality in Immunocompromised Patients with Severe Pneumonia in Intensive Care Units: A Single-Center, Retrospective Cohort Study

Development and validation a nomogram prediction model for early diagnosis of bloodstream infections in the intensive care unit

Development of Prediction Models for Carbapenem-Resistant Klebsiella Pneumoniae Acquisition and Prognosis in Adult Patients

Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort study

A Model for Predicting Nosocomial Carbapenem-Resistant Klebsiella Pneumoniae Infection.

Prediction of Prognosis in Adult Patients With Carbapenem-Resistant Klebsiella pneumoniae Infection.

Development and Validation of a Prognostic Nomogram for Cerebral Infarction Patients in Intensive Care Units: a Retrospective Cohort Study

Development and validation of a nomogram for predicting in-hospital survival rates of patients with COVID-19

Risk factors and predictive model for nosocomial infections by extensively drug-resistant Acinetobacter baumannii

Development and External Validation of an Evidence-based Risk Prediction Model for Multidrug-resistant Bacterial Infections in ICU Patients

Evaluating the Efficiency of a Nomogram Based on the Data of Neurosurgical Intensive Care Unit Patients to Predict Pulmonary Infection of Multidrug-Resistant Acinetobacter Baumannii.